Ambrx Biopharma American Price History
AMAMDelisted Stock | USD 15.73 0.71 4.73% |
If you're considering investing in Ambrx Stock, it is important to understand the factors that can impact its price. As of today, the current price of Ambrx Biopharma stands at 15.73, as last reported on the 23rd of January, with the highest price reaching 15.99 and the lowest price hitting 14.91 during the day. We have found twenty-nine technical indicators for Ambrx Biopharma American, which you can use to evaluate the volatility of the firm. Please confirm Ambrx Biopharma's mean deviation of 3.64, and Risk Adjusted Performance of 0.1057 to double-check if the risk estimate we provide is consistent with the expected return of 0.0%.
Ambrx Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Ambrx |
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
AMAM |
Based on monthly moving average Ambrx Biopharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Ambrx Biopharma by adding Ambrx Biopharma to a well-diversified portfolio.
Ambrx Biopharma Stock Price History Chart
There are several ways to analyze Ambrx Stock price data. The simplest method is using a basic Ambrx candlestick price chart, which shows Ambrx Biopharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Ambrx Stock Price History Data
The price series of Ambrx Biopharma for the period between Fri, Oct 25, 2024 and Thu, Jan 23, 2025 has a statistical range of 7.52 with a coefficient of variation of 14.71. The prices are distributed with arithmetic mean of 13.75. The median price for the last 90 days is 14.41. The company had 1:1 stock split on 12th of October 2023.Open | High | Low | Close | Volume | ||
01/23/2025 | 15.02 | 15.99 | 14.91 | 15.73 | ||
07/24/2023 | 15.02 | 15.99 | 14.91 | 15.73 | 302,158 | |
07/21/2023 | 15.00 | 15.11 | 14.61 | 15.03 | 334,547 | |
07/20/2023 | 15.96 | 16.03 | 15.14 | 15.30 | 197,631 | |
07/19/2023 | 15.67 | 16.15 | 15.43 | 15.84 | 296,416 | |
07/18/2023 | 14.79 | 15.86 | 14.79 | 15.74 | 236,863 | |
07/17/2023 | 14.71 | 15.22 | 14.49 | 14.91 | 125,978 | |
07/14/2023 | 14.05 | 15.01 | 13.78 | 14.73 | 188,685 | |
07/13/2023 | 13.70 | 14.08 | 13.62 | 13.94 | 215,378 | |
07/12/2023 | 13.33 | 14.12 | 13.16 | 13.55 | 446,332 | |
07/11/2023 | 14.51 | 14.85 | 13.26 | 13.27 | 489,018 | |
07/10/2023 | 15.00 | 15.22 | 14.43 | 14.56 | 471,172 | |
07/07/2023 | 16.10 | 16.37 | 14.76 | 15.15 | 486,442 | |
07/06/2023 | 16.47 | 16.52 | 15.89 | 16.34 | 297,523 | |
07/05/2023 | 16.17 | 16.86 | 15.74 | 16.60 | 361,430 | |
07/03/2023 | 16.59 | 16.59 | 15.91 | 16.16 | 163,269 | |
06/30/2023 | 16.34 | 16.63 | 16.16 | 16.46 | 264,643 | |
06/29/2023 | 16.17 | 16.64 | 15.82 | 16.31 | 295,765 | |
06/28/2023 | 16.21 | 16.58 | 15.70 | 16.10 | 299,441 | |
06/27/2023 | 16.07 | 16.55 | 15.90 | 16.21 | 287,112 | |
06/26/2023 | 15.31 | 16.07 | 15.24 | 15.96 | 237,388 | |
06/23/2023 | 15.90 | 16.00 | 15.31 | 15.39 | 207,892 | |
06/22/2023 | 15.88 | 16.15 | 15.41 | 15.90 | 196,061 | |
06/21/2023 | 16.23 | 16.42 | 15.20 | 16.03 | 419,639 | |
06/20/2023 | 15.01 | 16.29 | 14.69 | 16.10 | 496,554 | |
06/16/2023 | 14.70 | 15.46 | 14.50 | 15.01 | 384,928 | |
06/15/2023 | 14.42 | 14.95 | 13.92 | 14.67 | 277,244 | |
06/14/2023 | 14.90 | 15.10 | 14.50 | 14.56 | 203,013 | |
06/13/2023 | 14.24 | 14.83 | 13.93 | 14.52 | 221,162 | |
06/12/2023 | 14.70 | 14.90 | 14.23 | 14.51 | 351,875 | |
06/09/2023 | 14.40 | 14.98 | 14.23 | 14.70 | 305,159 | |
06/08/2023 | 13.62 | 14.73 | 13.34 | 14.41 | 434,084 | |
06/07/2023 | 12.69 | 13.85 | 11.82 | 13.68 | 714,148 | |
06/06/2023 | 13.28 | 13.81 | 12.51 | 12.90 | 561,041 | |
06/05/2023 | 14.67 | 14.90 | 13.03 | 13.27 | 668,991 | |
06/02/2023 | 15.25 | 15.25 | 14.36 | 14.92 | 365,702 | |
06/01/2023 | 14.69 | 15.06 | 14.09 | 14.53 | 337,033 | |
05/31/2023 | 14.90 | 15.00 | 14.39 | 14.76 | 408,410 | |
05/30/2023 | 14.05 | 15.00 | 13.57 | 14.81 | 423,269 | |
05/26/2023 | 14.08 | 14.67 | 13.59 | 14.01 | 475,975 | |
05/25/2023 | 15.00 | 15.00 | 13.88 | 14.03 | 562,218 | |
05/24/2023 | 13.96 | 15.29 | 13.58 | 14.97 | 1,129,003 | |
05/23/2023 | 13.54 | 15.09 | 13.54 | 14.23 | 701,994 | |
05/22/2023 | 12.89 | 13.66 | 12.89 | 13.48 | 264,280 | |
05/19/2023 | 14.25 | 14.25 | 12.87 | 13.00 | 438,104 | |
05/18/2023 | 14.38 | 14.60 | 13.50 | 13.77 | 701,702 | |
05/17/2023 | 14.24 | 14.48 | 13.06 | 14.35 | 1,481,041 | |
05/16/2023 | 12.08 | 13.78 | 11.62 | 13.60 | 1,693,890 | |
05/15/2023 | 11.68 | 12.17 | 11.41 | 12.06 | 863,766 | |
05/12/2023 | 11.20 | 11.64 | 10.81 | 11.64 | 148,810 | |
05/11/2023 | 11.51 | 11.75 | 11.18 | 11.29 | 258,082 | |
05/10/2023 | 11.65 | 12.07 | 11.39 | 11.69 | 315,351 | |
05/09/2023 | 11.57 | 11.96 | 11.21 | 11.88 | 196,411 | |
05/08/2023 | 11.77 | 12.16 | 10.94 | 11.82 | 500,710 | |
05/05/2023 | 11.90 | 12.50 | 11.51 | 11.78 | 480,633 | |
05/04/2023 | 11.56 | 11.93 | 11.05 | 11.83 | 547,787 | |
05/03/2023 | 9.77 | 11.95 | 9.77 | 11.64 | 800,858 | |
05/02/2023 | 9.94 | 10.04 | 9.16 | 9.79 | 287,182 | |
05/01/2023 | 9.65 | 10.53 | 9.65 | 9.92 | 261,644 | |
04/28/2023 | 9.44 | 9.75 | 9.21 | 9.64 | 143,559 | |
04/27/2023 | 9.16 | 9.83 | 8.90 | 9.61 | 224,667 |
About Ambrx Biopharma Stock history
Ambrx Biopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Ambrx is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Ambrx Biopharma American will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Ambrx Biopharma stock prices may prove useful in developing a viable investing in Ambrx Biopharma
Ambrx Biopharma Inc., a clinical-stage biologics company, discovers and develops engineered precision biologics using its proprietary expanded genetic code technology platform. The company was incorporated in 2003 and is headquartered in La Jolla, California. Ambrx Biopharma operates under Biotechnology classification in the United States and is traded on New York Stock Exchange. It employs 81 people.
Ambrx Biopharma Stock Technical Analysis
Ambrx Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Did you try this?
Run AI Portfolio Architect Now
AI Portfolio ArchitectUse AI to generate optimal portfolios and find profitable investment opportunities |
All Next | Launch Module |
Ambrx Biopharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Ambrx Biopharma's price direction in advance. Along with the technical and fundamental analysis of Ambrx Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Ambrx to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.1057 | |||
Jensen Alpha | 0.5976 | |||
Total Risk Alpha | 0.4314 | |||
Sortino Ratio | 0.1045 | |||
Treynor Ratio | (1.35) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Consideration for investing in Ambrx Stock
If you are still planning to invest in Ambrx Biopharma American check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Ambrx Biopharma's history and understand the potential risks before investing.
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Transaction History View history of all your transactions and understand their impact on performance | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Fundamental Analysis View fundamental data based on most recent published financial statements |